Health officials urge vigilance against imported measles
The national disease control agency has requested that health care workers remain vigilant for imported measles cases after one more case from abroad was confirmed last month.
As of Monday, 17 cases of lumpy skin disease had been confirmed and 638 cattle were culled. Farmers are vaccinating their cattle against the disease, with the government planning to import 1.7 million more doses of the vaccine early next month.
SK bioscience applies for emergency Covid-19 vaccine approval
SK bioscience has applied for emergency use approval for Novavax’s updated Covid-19 vaccine.
First lady praises cooperation with Indonesia on global health
First lady Kim Keon Hee said that Korea and Indonesia are working together to contribute to global health and fight against infectious diseases in a visit to Bio Farma, Indonesia's leading vaccine manufacturer, in Jakarta on Wednesday.
Gov't triples compensation for Covid-19 vaccine deaths to 30 million won
Currently families of victims who died within 42 days of receiving the vaccine and whose autopsy results were inconclusive are eligible to a 10 million won payment.
Covid patients to cough up more starting Thursday
Most people who catch Covid-19 in Korea will be forced to shoulder a greater personal burden after the virus is downgraded on Thursday, marking the end of large-scale state support and monitoring of patients.
SK bioscience restarts flu shot production after 2 years
The flu season is back in full swing, and so is SK bioscience’s production of Korea’s first and only cell-based influenza vaccine.
SK bioscience signs manufacturing deal with MSD for Ebola vaccine candidate
SK bioscience inked a manufacturing deal with MSD for an Ebola vaccine candidate.
SK bioscience to invest big in vaccines, CDMO over next 5 years
SK bioscience will invest 2.4 trillion won ($1.8 billion) over five years to strengthen its vaccine and contract development and manufacturing organization (CDMO) businesses, including two possible mergers and acquisitions (M&As).
LG Chem, Unicef sign $200M deal to supply vaccines to children globally
LG Chem inked a $200 million contract with Unicef to supply polio and pentavalent vaccines to 80 million children all over the world.